the Effect of High Caloric Oral Nutritional Supplements on Growth and Development of Malnourished Children
EHCONSGDMC
1 other identifier
interventional
200
1 country
13
Brief Summary
The goal of this clinical trial is to investigate the effect of high caloric oral nutritional supplements on body proportion, weight, linear growth pattern, neuropsychological development level and related health aspects (gut health, immune function, quality of life, etc.) in participants aged 1 to 3 years who are malnourished (underweight and wasting),as well as to evaluate the safety of applying high caloric oral nutritional supplements. Participants will receive nutritional education and daily high caloric oral nutritional supplements(experimental group),or will receive nutritional education and dietary instruction(control group).This study may provide data to support the development of clinical intervention strategies for malnourished Chinese children.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2024
13 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 16, 2023
CompletedFirst Posted
Study publicly available on registry
June 22, 2023
CompletedStudy Start
First participant enrolled
June 17, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 10, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 10, 2026
CompletedMarch 18, 2026
November 1, 2025
1.7 years
May 16, 2023
March 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
BMI for Age Z-score(BAZ)
Trained research assistants or health care practitioners obtain weight in kilograms and height in centimeters (mean of 3 consecutive measurements). Height and weight will be combined to report BMI in kg/m\^2.Then, the BAZ is calculated using WHO2011v3.2.2 software.
at 6 months of enrollment
Secondary Outcomes (14)
Dietary Diary
at 0, 1, 2, 3, 6 and 12 months of enrollment
BMI for Age Z-score(BAZ)
at 0, 1, 2, 3 and 12 months of enrollment
Weight for Age Z-score(WAZ)
at 0, 1, 2, 3, 6 and 12 months of enrollment
Height for Age Z-score(HAZ)
at 0, 1, 2, 3, 6 and 12 months of enrollment
Gesell Developmental Scale Test
at 0, 6, and 12 months of enrollment
- +9 more secondary outcomes
Study Arms (2)
high caloric oral nutritional supplements group
EXPERIMENTALParticipants aged 1 to 3 years who are malnourished (underweight and wasting). They will receive nutritional education,dietary instruction and daily high caloric oral nutritional supplements for 12 months.
nutritional education and dietary guidance group
ACTIVE COMPARATORParticipants aged 1 to 3 years who are malnourished (underweight and wasting). They will receive nutrition education and dietary instruction.
Interventions
High caloric oral nutritional supplements (which can supplement 30% of the energy requirement) is given daily, and the recommended amount of energy and protein is referred to the 2013 Chinese Dietary Nutrient Reference Intake Table. At 6 months of enrollment, participants will be asked to evaluate whether to continue feeding according to the experimental group protocol or to stop to ensure proper nutritional intake.
After enrollment,health education information is pushed approximately every 4 weeks through the WeChat platform or/and short text messages to parents.
At follow-up visits at 0, 1, 2, 3, 6,and 12 months after enrollment, a professionally trained pediatrician give the participant's guardian dietary instructions appropriate to the age stage and physical condition of the child. Each session lasts approximately 10 minutes.
Eligibility Criteria
You may qualify if:
- Aged 1-3 years
- BMI for Age Z-score\<-2
- Height-for-age z score\<-2
- Total daily energy intake\<75% of recommended nutrient intake
- The child's guardian is willing to participate in this study and sign an informed consent form.
You may not qualify if:
- Chronic or severe infectious disease (e.g., chronic hepatitis, HIV or tuberculosis infection)
- Certain congenital or genetic diseases affecting physical growth and development (congenital heart disease, Down's syndrome, infantile anorexia nervosa, etc.), malignancies and use of drugs (diuretics, appetite stimulants, steroids and growth hormones, etc.)
- Severe gastrointestinal disorders (e.g., celiac disease, short bowel syndrome, inflammatory bowel disease, etc.)
- Acute and chronic respiratory/digestive tract infections within 2 weeks prior to enrollment
- Allergy or contraindication to any of the ingredients in the high-energy total nutrition formula used in this study
- Have used high-energy enteral nutrition preparations for the last 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Children's Hospital of Chongqing Medical Universitylead
- Anhui Provincial Children's Hospitalcollaborator
- Hunan Children's Hospitalcollaborator
- Baoji Maternity and Child Healthcare Hospitalcollaborator
- Chengdu Women's and Children's Central Hospitalcollaborator
- Guiyang Maternity and Child Health Care Hospitalcollaborator
- Guangzhou Women and Children's Medical Centercollaborator
- Jiangxi Maternal and Child Health Hospitalcollaborator
- Kunming Children's Hospitalcollaborator
- Nanjing Maternity and Child Health Care Hospitalcollaborator
- Children's Hospital of The Capital Institute of Pediatricscollaborator
- Xianyang Children's Hospitalcollaborator
- Nestle Health Sciencecollaborator
- The First Hospital of Jilin Universitycollaborator
Study Sites (13)
Anhui Provincial Children's Hospital
Hefei, Anhui, 230001, China
Children's Hospital of The Capital Institute of Pediatrics
Beijing, Beijing Municipality, 100020, China
The First Hospital of Jilin University
Jilin, Changchun, China
Growth, Development and Mental health of Children and Adolescence Center
Chongqing, Chongqing Municipality, 400014, China
Guangzhou Women and Children's Medical Center
Guangzhou, Guangdong, 510200, China
Guiyang Maternity and Child Health Care Hospital
Guiyang, Guizhou, 550003, China
Hunan Children's Hospital
Changsha, Hunan, 410007, China
Nanjing Maternity and Child Health Care Hospital
Nanjing, Jiangsu, 210004, China
Jiangxi Maternal and Child Health Hospital
Nanchang, Jiangxi, 330006, China
Baoji Maternity and Child Healthcare Hospital
Baoji, Shanxi, 721000, China
Xianyang Children's Hospital
Xianyang, Shanxi, 712000, China
Chengdu Women's and Children's Central Hospital,School of Medicine,University of Electronic Science and Technology of China
Chengdu, Sichuan, 610091, China
Kunming Children's Hospital
Kunming, Yunnan, 650000, China
Related Publications (1)
Hemming K, Taljaard M, McKenzie JE, Hooper R, Copas A, Thompson JA, Dixon-Woods M, Aldcroft A, Doussau A, Grayling M, Kristunas C, Goldstein CE, Campbell MK, Girling A, Eldridge S, Campbell MJ, Lilford RJ, Weijer C, Forbes AB, Grimshaw JM. Reporting of stepped wedge cluster randomised trials: extension of the CONSORT 2010 statement with explanation and elaboration. BMJ. 2018 Nov 9;363:k1614. doi: 10.1136/bmj.k1614.
PMID: 30413417BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Li Chen, doctor
Children's Hospital of Chongqing Medical University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor, Director
Study Record Dates
First Submitted
May 16, 2023
First Posted
June 22, 2023
Study Start
June 17, 2024
Primary Completion
March 10, 2026
Study Completion
March 10, 2026
Last Updated
March 18, 2026
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share
Data is confidential during the study.